DELFINI LISA (Chief Financial Officer) sold 2.0% of their position (682.00 shares) of TREVI THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/14/2023ACC: 0001209191-23-045595
Officer· Chief Financial Officer
Since Aug 2021
-682.00
Net shares
Net seller
$1.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.29K acquired · 2.97K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.29K
Price / share
$0.51
Trade value
$1.17K
% of position
7.3%
8/11/2023
31.20K→33.50K
Common Stock
Direct
Shares
−682.00
Price / share
$2.36
Trade value
$1.61K
% of position
2.0%
8/11/2023
33.50K→32.81K
Total
Net shares
+1.61K
Net value
-$438.31
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2023 | M · Option Exercise | +2.29K | $0.51 | $1.17K | 7.3% | 31.20K | 33.50K |
| Common Stock Direct | 8/11/2023 | S · Sale | −682.00 | $2.36 | $1.61K | 2.0% | 33.50K | 32.81K |
| Total | +1.61K | -$438.31 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
2.29K shares
Shares
−2.29K
Strike price
0.511
Held after
68.75K
Exercisable
—
8/11/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock2.29K shares | 8/11/2023 | M · Option Exercise | −2.29K | 0.511 | — | 68.75K |